RELMADA THERAPEUTICS INC (RLMD:NASDAQ)
$4.35 -0.09 (-2.027%)
Analysed RELMADA THERAPEUTICS INC (RLMD:NASDAQ) News Sources
Relmada Therapeutics (RLMD): 10 Best Growth Stocks Under $30 to Buy Now
19-06-2026
yahoo.com
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
29-06-2026
yahoo.com
Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
16-07-2026
yahoo.com
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
28-07-2026
yahoo.com
Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
06-08-2026
yahoo.com
Relmada Therapeutics Inc (RLMD) (Q2 2026) Earnings Call Highlights: Strong Phase 2 Data and FDA ...
07-08-2026
yahoo.com
Relmada Therapeutics Q2 Earnings Call Highlights
07-08-2026
marketbeat.com
Down 29.6% in 4 Weeks, Here's Why Relmada Therapeutics (RLMD) Looks Ripe for a Turnaround
11-08-2026
yahoo.com
Here's Why Relmada Therapeutics (RLMD) Is a Great 'Buy the Bottom' Stock Now
25-08-2026
yahoo.com
After Plunging 18.5% in 4 Weeks, Here's Why the Trend Might Reverse for Relmada Therapeutics (RLMD)
31-08-2026
yahoo.com
What is the current price of RELMADA THERAPEUTICS INC (RLMD:NASDAQ)?
The current price of RELMADA THERAPEUTICS INC (RLMD:NASDAQ) is $4.35.
RELMADA THERAPEUTICS INC (RLMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of RELMADA THERAPEUTICS INC (RLMD:NASDAQ) since the previous trading day is $-0.09.
RELMADA THERAPEUTICS INC (RLMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of RELMADA THERAPEUTICS INC (RLMD:NASDAQ) since the previous trading day is -2.027%.
What is the most recent average sentiment score for RELMADA THERAPEUTICS INC (RLMD:NASDAQ)?
The most recent average sentiment score for RELMADA THERAPEUTICS INC (RLMD:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for RELMADA THERAPEUTICS INC (RLMD:NASDAQ)?
The most recent sentiment for RELMADA THERAPEUTICS INC (RLMD:NASDAQ) is .
SEC-8K** Filing Available For RELMADA THERAPEUTICS INC (RLMD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.